Toronto Dominion Bank Neurocrine Biosciences Inc Transaction History

Toronto Dominion Bank

$55.7 Billion
Q3 2024

A detailed history of Toronto Dominion Bank transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Toronto Dominion Bank holds 12,684 shares of NBIX stock, worth $1.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,684

Previous 12,684 -0.0%

Holding current value

$1.59 Million

Previous $1.46 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$114.58 - $153.15 $358,749 - $479,512	3,131 Added 32.78%	12,684 $1.46 Million
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $53,652 - $58,707	-410 Reduced 4.12%	9,553 $1.32 Million
Q1 2024 May 14, 2024	SELL	$130.4 - $143.74 $434,101 - $478,510	-3,329 Reduced 25.05%	9,963 $1.37 Million
Q4 2023 Feb 13, 2024	SELL	$106.07 - $132.76 $2.06 Million - $2.58 Million	-19,446 Reduced 59.4%	13,292 $1.75 Million
Q3 2023 Feb 14, 2024	SELL	$94.02 - $117.1 $450,731 - $561,377	-4,794 Reduced 12.77%	32,738 $3.68 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $450,731 - $561,377	-4,794 Reduced 12.77%	32,738 $3.68 Million
Q2 2023 Feb 14, 2024	BUY	$89.53 - $104.87 $2.17 Million - $2.54 Million	24,240 Added 182.37%	37,532 $3.54 Million
Q2 2023 Aug 10, 2023	BUY	$89.53 - $104.87 $896,642 - $1.05 Million	10,015 Added 36.4%	37,532 $3.54 Million
Q1 2023 May 11, 2023	SELL	$94.11 - $123.02 $123,284 - $161,156	-1,310 Reduced 4.54%	27,517 $2.78 Million
Q4 2022 Feb 07, 2023	BUY	$106.72 - $127.06 $841,487 - $1 Million	7,885 Added 37.65%	28,827 $3.44 Million
Q3 2022 Nov 09, 2022	SELL	$92.03 - $107.81 $28,253 - $33,097	-307 Reduced 1.44%	20,942 $2.22 Million
Q2 2022 Aug 11, 2022	BUY	$75.79 - $100.07 $71,091 - $93,865	938 Added 4.62%	21,249 $2.07 Million
Q1 2022 May 09, 2022	SELL	$72.45 - $94.81 $2.42 Million - $3.16 Million	-33,350 Reduced 62.15%	20,311 $1.9 Million
Q4 2021 Feb 04, 2022	BUY	$79.65 - $106.22 $3.21 Million - $4.28 Million	40,310 Added 301.92%	53,661 $4.57 Million
Q3 2021 Nov 08, 2021	SELL	$86.18 - $99.03 $7,325 - $8,417	-85 Reduced 0.63%	13,351 $1.28 Million
Q2 2021 Aug 13, 2021	BUY	$89.43 - $102.27 $1.2 Million - $1.37 Million	13,436 New	13,436 $1.31 Million

Others Institutions Holding NBIX

# of Institutions

625

Shares Held

94.2M

Call Options Held

632K

Put Options Held

621K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.

Account

Toronto Dominion Bank Neurocrine Biosciences Inc Transaction History